POLYNUCLEOTIDES AND POLYPEPTIDES, THEIR USE IN DIAGNOSIS AND TREATMENT OF CARDIAC, RENAL OR INFLAMMARY DISEASE

The invention concerns secreted factors encoded by clones in the series P00184-P00697 as well as polynucleotides encoding them. The invention further concerns methods for producing such factors and their use in diagnosis and treatment of cardiac, renal or inflammatory diseases. Cette invention a tra...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: STANTON, LAWRENCE, W, WHITE, R., TYLER
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The invention concerns secreted factors encoded by clones in the series P00184-P00697 as well as polynucleotides encoding them. The invention further concerns methods for producing such factors and their use in diagnosis and treatment of cardiac, renal or inflammatory diseases. Cette invention a trait à de nouveaux facteurs sécrétés codés par les clones P00184 D11 (SEQ ID NO:1), P00185 D11(SEQ ID NO:3), P00188 D12 (SEQ ID NO:5), P00188 E01 (SEQ ID NO:7), P00194 G01 (SEQ ID NO:9), P00194 G05 (SEQ ID NO:11), P00194 H10 (SEQ ID NO:13), P00199 D08 (SEQ ID NO:15), P00203 D04 (SEQ ID NO:17), P00203 E06 (SEQ ID NO:19), P00209 F06 (SEQ ID NO:21), P00219 D02 (SEQ ID NO:23), P00219 F06 (SEQ ID NO:25), P00220 H05 (SEQ ID NO:27), P00222 G03 (SEQ ID NO:29), P00225 C01 (SEQ ID NO:32), P00227 D11 (SEQ ID NO:34), P00228 F03 (SEQ ID NO:36), P00233 H08 (SEQ ID NO:38), P00235 G08 (SEQ ID NO:40), P00239 C11 (SEQ ID NO:42), P00240 E05 (SEQ ID NO:45), P00247 A04 (SEQ ID NO:50), P00248 B04 (SEQ ID NO:52), P00249 F09 (SEQ ID NO:54), P00258 A10 (SEQ ID NO:56), P00262 C10 (SEQ ID NO:58), P00269 H08 (SEQ ID NO:62), P00628 H02 (SEQ ID NO:66), P00629 C08 (SEQ ID NO:68), P00641 G11 (SEQ ID NO:71), P00648 E12 (SEQ ID NO:73), P00697 C03 (SEQ ID NO:75), ainsi qu'à d'autres homologues et variants mammaliens de ce facteur. Elle concerne aussi des polynucléotides les codant. Elle porte, en outre, sur des méthodes ainsi que sur des moyens permettant de produire ces facteurs comme sur l'usage qui en est fait en matière de diagnostic et de traitement de différentes maladies cardiaques, rénales ou inflammatoires.